Notes from some crypt watchers: Regulation of renewal in the mouse intestinal epithelium

Current Opinion in Cell Biology

Volumn 10, Issue 6, 1998, Pages 702-709

  Stappenbeck, Thaddeus S ^a   Wong, Melissa H ^a   Saam, Jennifer R ^a   Mysorekar, Indira U ^a   Gordon, Jeffrey I ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; BASE MISPAIRING; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; EPITHELIUM CELL; INTESTINE CANCER; INTESTINE EPITHELIUM; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 0031798066     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(98)80110-5     Document Type: Article

References (63)

1. Loeffler M, Birke A, Winton D, Potten C. Somatic mutation, monoclonality and stochastic models of stem cell organization in the intestinal crypt. J Theor Biol. 160:1993;471-491.
2. Calvert R, Pothier P. Migration of fetal intestinal intervillous cells in neonatal mice. Anat Rec. 227:1990;199-206.
3. Schmidt GH, Winton DJ, Ponder BAJ. Development of the pattern of cell renewal in the crypt-villus unit of chimaeric mouse small intestine. Development. 103:1988;785-790.
4. Totafurno J, Bjerknes M, Cheng H. The crypt cycle. Crypt and villus production in the adult intestinal epithelium. Biophys J. 52:1987;279-294.
5. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 87:1996;159-170.
6. Kinzler KW, Vogelstein B. Landscaping the cancer terrain. of outstanding interest Science. 280:1998;1036-1037 An expansion of their 1996 Cell paper [5]. An elegant conceptualization of how gatekeepers (genes that control levels of proliferation in self-renewing systems), caretakers (genes that ensure the integrity of the genome), and landscapers (genes that participate in mesenchymal-epithelial crosstalk) affect tumorigenesis in the gut.
7. Su L-K, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science. 256:1992;668-670.
8. Shibata H, Toyama K, Shioya H, Ito M, Hirota M, Hasegawa S, Matsumoto H, Takano H, Akiyama T, Toyoshima K, et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. of outstanding interest Science. 278:1997;120-123 This paper reports disruption of the Apc gene in the colonic epithelium in mice by administration of an enema containing an adenoviral vector that directs expression of Cre recombinase. Multiple tumors form within four weeks, thus proving that loss of Apc alone is sufficient for initiation of tumori-genesis. The need for developing strategies for inducing gene disruption at various points in time is great in the case of the gut, which continues to evolve as animals age. Targeting the stem cell is also critical. Adenoviral enemas appear to be a workable solution, at least for the distal gut, and you do not have to worry about altering the genetic background.
9. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA. 92:1995;4482-4486.
10. 2).
11. Novelli MR, Williamson JA, Tomlinson IP, Elia G, Hodgson SV, Talbot IC, Bodmer W, Wright NA. Polyclonal origin of colonic adenomas in an XO↔XY patient with FAP. Science. 272:1996;1187-1190.
12. Bjerknes M, Cheng H, Kim H, Schnitzler M, Gallinger S. Clonality of dysplastic epithelium in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res. 57:1997;355-361.
13. Min. Bottom line: polyclonal adenomas are observed. Polyclonality in microadenomas argues against simple collision of two independently initiated clones. The authors provide several possible scenarios to explain how multiply initiated clones could interact to promote tumorigenesis. The issue of polyclonality may have relevance to the initiation of other epithelial cancers: the mouse gut provides a good system for documenting and studying this interesting question.
14. Bjerknes M, Cheng H, Hay K, Gallinger S. APC mutation and the crypt cycle in murine and human intestine. Am J Pathol. 150:1997;833-839.
15. Behrens J, Jerchow B-A, Würtele M, Grimm J, Asbrand C, Wirtz R, Kühl M, Wedlich D, Birchmeier W. Functional interaction of an axin homolog, conductin, with β-catenin, APC and GSK3β Science. 280:1998;596-599.
16. Brown JD, Moon RT. Wnt signaling: why is everything so negative? Curr Opin Cell Biol. 10:1998;182-187.
17. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642.
18. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R. Nuclear localization of β-catenin by interaction with transcription factor LEF-1. Mech Dev. 59:1996;3-10.
19. -/- colon carcinoma. of outstanding interest Science. 275:1997;1784-1787 See annotation to [20].
20. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. of outstanding interest Science. 275:1997;1787-1790 This paper and the report by Korinek [19] use cell lines derived from human-colon-carcinoma to demonstrate that mutations in APC are associated with transcriptional activation of a reporter gene containing a DNA-binding site recognized by all Tcf family members. Important evidence is presented that Apc affects the availability of β-catenin for partnering with Tcf-4.
21. Wong MH, Rubinfeld B, Gordon JI. Effects of forced expression of an N-terminal truncated β-catenin on mouse intestinal epithelial homeostasis. of special interest J Cell Biol. 141:1998;765-777 An in vivo experiment showing that augmenting β-catenin levels in the intestinal epithelium of chimeric mice enhances proliferation in the crypt. An accompanying induction of E-cadherin expression produces a slowing of cell migration, and illustrates how β-catenin affects both proliferation and adhesion.
22. -/- mice but by E16.5, the intervillus epithelium lacks proliferating cells; what remains are cells that resemble the differentiated cells on the villus. In conclusion, Tcf-4 is needed to sustain epithelial proliferation. Unfortunately, mice die by postnatal day 1 so the role of Tcf-4 in adult crypts will have to be defined by conditional targeting. Colonic crypts in the knockout animals appeared normal, but, unlike small intestinal crypts, colonic crypts also have Tcf-3.
23. Yanagawa S-I, Lee J-S, Haruna T, Oda H, Uemura T, Takeichi M, Ishimoto A. Accumulation of Armadillo induced by Wingless, Dishevelled and dominant negative Zeste-white 3 leads to elevated DE-cadherin in Drosophila clone 8 wing disc cells. J Biol Chem. 272:1997;25243-25251.
24. Korinek V, Barker N, Willert K, Molenaar M, Roose J, Wagenaar G, Markman M, Lamers W, Destree O, Clevers H. Two members of the Tcf family implicated in Wnt/β-catenin signaling during embryogenesis in the mouse. Mol Cell Biol. 18:1998;1248-1256.
25. Min-induced intestinal neoplasia. Cell. 81:1995;957-966.
26. Min/+ littermates with just the endogenous B6 Pla2g2a allele. This experiment, which kept the genetic background constant, provides very strong evidence that Pla2g2a is Mom1 (modifier of Min). The big question: what is the mechanism by which this phospholipase affects tumorigenesis?
27. Δ716 knockout mice by inhibition of cyclooxygenase 2 (Cox-2). Cell. 87:1996;803-809.
28. Dragani TA, Manenti G. Mom1 leads the pack. Nat Genet. 17:1997;7-8.
29. Lorentz O, Duluc I, De Arcangelis A, Simon-Assmann P, Kedinger M, Freund J-N. Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J Cell Biol. 139:1997;1553-1565.
30. -/- mice should be informative, as long as the genetic backgrounds are kept constant.
31. Drucker DJ, Ehrlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA. 93:1996;7911-7916.
32. Duluc I, aiFreund J-N, Leberquier C, Kedinger M. Fetal endoderm primarily holds the temporal and positional information required for mammalian intestinal development. J Cell Biol. 126:1994;211-221.
33. Marsh MN, Trier JS. Morphology and cell proliferation of subepithelial fibroblasts in adult mouse jejenum. Gastroenterology. 67:1974;622-645.
34. Komano H, Fujiura Y, Kawaguchi M, Matsumoto S, Hashimoto Y, Obana S, Mombaerts P, Tonegawa S, Yamamoto H, Itohara S, et al. Homeostatic regulation of intestinal epithelia by intraepithelial γδ T cells. Proc Natl Acad Sci USA. 92:1995;6147-6151.
35. Kaestner KH, Bleckmann SC, Monaghan AP, Schlöndorff J, Mincheva A, Lichter P, Schütz G. Clustered arrangement of winged helix genes Fkh6 and Mfh1: Possible implications for mesoderm development. Development. 122:1996;1751-1758.
36. Kaestner KH, Silberg DG, Traber PG, Schutz G. The mesenchymal winged helix transcription factor Fkh6 is required for the control of gastrointestinal proliferation and differentiation. of outstanding interest Genes Dev. 11:1997;1583-1595 Loss of forkhead 6 homolog (Fkh6) from the gut mesoderm produces a prominent phenotype in late fetal life. Mesenchymal invagination is delayed, thereby delaying formation of villi and proliferation is not restricted to the intervillus epithelium. Most knockout mice die during the first three postnatal weeks. Those that survive have increased crypt proliferation, elongated villi (but no dividing cells in the villus epithelium), and goblet- cell hyperplasia. These results indicate that Fkh6 is involved in mesenchymal-epithelial signaling and negatively regulates proliferation. An interesting issue is why there are differences in the distribution of dividing cells in the fetal versus adult intestine.
37. Heldin C-H, Miyazono K, ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471.
38. Hahn SA, Schutte M, Shamsul Hoque ATM, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350-353.
39. Zhou S, Buckhaults P, Zawel L, Bunz F, Riggins G, Le Dai J, Kern SE, Kinzler KW, Vogelstein B. Targeted deletion of Smad4 shows it is required for transforming growth factor β and activin signaling in colorectal cancer cells. of outstanding interest Proc Natl Acad Sci USA. 95:1998;2412-2416 Homologous recombination was used in colorectal cancer cells to disrupt SMAD4. Smad4-deficient cells are unable to transduce signals from transforming growth factor β (TGFβ) or activin. This study provided direct evidence in human cells that Smad4 mediates pathway-specific signaling by TGFβ-family members.
40. Δ716/+ mice, the compound heterozygotes develop adenomas with pronounced stromal hyperplasia. By 20 weeks of age >50% of the lesions have progressed to adenocarcinoma. Note that Smad4 is absent from the epithelial component of these adenomas, due to loss of the wild-type allele, but remains detectable in the mesenchymal component. Is the epithelium driving the mesenchymal response? Desmoplasia refers to the excessive production of connective tissue surrounding the leading edges of invasive carcinomas. These mice may represent a model for studying the origins of desmoplasia.
41. -/- mice die by embryonic day 7.5 without detectable mesoderm, and with abnormalities in development of their visceral endoderm.
42. Howe JR, Roth S, Ringold JC, Summers RW, Järvinen HJ, Sistonen P, Tomlinson IPM, Houlston RS, Bevan S, Mitros FA, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. of special interest Science. 280:1998;1086-1088 Families with an autosomal dominant disease, juvenile polyposis, develop hamartomous polyps in their gut and are also predisposed to carcinoma. This study shows that in certain juvenile polyposis kindreds, these neoplasms are due to germline mutations in SMAD4.
43. Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PLM, Zheng Z, Liaw D, Caron S, Duboue B, Lin AY, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet. 7:1998;507-515.
44. +/- embryonic stem cells and wild-type blastocysts exhibit colonic hyperplasia, dysplasia and neoplasia. Increased numbers of fibroblasts surround crypts in areas of hyperplasia or dysplasia, raising the question of whether the proliferative abnormalities in the gut are a reflection of disorders in mesenchymal-epithelial cross talk.
45. Hentsch B, Lyons I, Li R, Hartley L, Lints TJ, Adams JM, Harvey RP. Hlx homeobox gene is essential for an inductive tissue interaction that drives expansion of embryonic liver and gut. Genes Dev. 10:1996;70-79.
46. Apelqvist Å, Ahlgren U, Edlund H. Sonic hedgehog directs specialized mesoderm differentiation in the intestine and pancreas. of special interest Curr Biol. 7:1997;804-810 Sonic hedgehog (Shh) is secreted throughout the fetal gut endoderm but is normally absent from the pancreatic endoderm. Forced expression of Shh in the pancreatic endoderm changes the identity of its associated mesoderm so that it resembles the intestinal mesoderm.
47. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10:1996;1433-1442.
48. Acharya S, Wilson T, Gradia S, Kane MF, Guerrette S, Marsischky GT, Kolodner R, Fishel R. hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci USA. 93:1996;13629-13634.
49. de Wind N, Dekker M, Berns A, Radman M, te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination and predisposition to cancer. Cell. 82:1995;321-330.
50. Reitmair A, Schmits R, Ewel A, Bapat B, Redston M, Mitri A, Waterhouse P, Mittrücker H-W, Wakeham A, Liu B, et al. Msh2 deficient mice are viable and susceptible to lymphoid tumors. Nat Genet. 11:1995;64-70.
51. Baker SM, Plug AW, Prolla TA, Bronner CE, Harris AC, Yao X, Christie D-M, Monell C, Arnheim N, Bradley A, et al. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet. 13:1996;336-342.
52. Edelmann W, Cohen PE, Kane M, Lau K, Morrow B, Bennett S, Umar A, Kunkel T, Cattoretti G, Chagnati R, et al. Meiotic pachytene arrest in Mlh1-deficient mice. Cell. 85:1996;1125-1134.
53. Reitmair AH, Redston M, Cai JC, Chuang TCY, Bjerknes M, Cheng H, Hay K, Gallinger S, Bapat B, Mak TW. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res. 56:1996;3842-3849.
54. Prolla TA, Baker SM, Harris AC, Tsao J-L, Yao X, Bronner CE, Zheng B, Gordon M, Reneker J, Arnheim N, et al. Tumor susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. of outstanding interest Nat Genet. 18:1998;276-279 The authors compare tumorigenesis in mice deficient for various mismatch repair enzymes and find remarkable differences. Pms1 knockout mice do not develop any tumors. Pms2 knockouts develop lymphomas but not gut tumors. Mlh1 knockout mice develop lymphomas as well as intestinal adenomas and adenocarcinomas.
55. Reitmair AH, Cai J-C, Bjerknes M, Redston M, Cheng H, Pind MTL, Hay K, Mitri A, Bapat BV, Mak TW, Gallinger S. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res. 56:1996;2922-2926.
56. -/- are unable to repair single base pair mismatches, although they can repair insertion or deletion mutations. Mice derived from these embryonic stem cells develop lymphoid and gut tumors.
57. Baker SM, Bronner CE, Zhang L, Plug AW, Robatzel M, Warren G, Elliott EA, Yu J, Ashley T, Arnheim N, et al. Male mice defective in the DNA mismatch repair gene Pms2 exhibit abnormal chromosome synapsis in meiosis. Cell. 82:1995;309-319.
58. Narayanan L, Fritzell JA, Baker SM, Liskay RM, Glazer PM. Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc Natl Acad Sci USA. 94:1997;3122-3127.
59. -/-: Min mice. Cancer Res. 58:1998;1087-1089.
60. Huang J, Papadopoulos N, McKinley AJ, Farrington SM, Curtis LJ, Wyllie AH, Zheng S, Willson JKV, Markowitz SD, Morin P, et al. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci USA. 93:1996;9049-9054.
61. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science. 268:1995;1336-1338.
62. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. of special interest Science. 275:1997;967-969 Demonstrates of the effects of microsatellite instability on the functional integrity of a gene likely to be involved in tumorigenesis: over 50% of colorectal cancers with unstable microsatellite sequences contained frameshift mutations in an 8 basepair tract of guanosines in BAX.
63. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512.